China approves HERNEXEOS® as first targeted oral treatment option for HER2-mutant advanced NSCLC at initial diagnosis Notified -
Together for Steatotic Liver Disease - The Hidden NCDs: SLD as the Next Global Public Health Priority Notified -
ARKAY Launches New 200 ml Mocktail Tetra Pack Collection: A Convenient, Alcohol-Free Grab-and-Go Beverage for Modern Consumers Notified -
Slovenian Tourist Board: Slovenia to Host the 2026 UEC Road European Championships This October Notified -
Boehringer Ingelheim’s oncology portfolio shows strong promise across multiple cancers at ASCO 2026 Notified -
Canada’s La Tablée des Chefs Wins F1® Allwyn Global Community Award and Receives €100,000 to Fight Food Insecurity Notified -
The European Medicines Agency Accepts Teva’s Marketing Authorization Application for Olanzapine Long-Acting Injectable (TEV-‘749) for the Treatment of Schizophrenia in Adults Notified -
Breaking the speed limit: Wood Mackenzie warns AI data centre power race threatens projects and consumers Notified -
Surge in EHS+ Platform Adoption Among Companies with Leaner Operations Signals Broader Market Shift, Cority Reports Notified -
